{
    "Trade/Device Name(s)": [
        "EZ Scan Plus Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Tyson Bioresearch, Inc.",
    "510(k) Number": "K072441",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052818"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "February 21, 2008",
    "Summary Letter Received Date": "February 25, 2008",
    "Submission Date": "August 18, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "EZ Scan Plus Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose oxidase enzymatic reaction"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for the EZ Scan Plus Blood Glucose Monitoring System for quantitative glucose testing in capillary whole blood using an electrochemical biosensor.",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from fingertip, palm, and forearm using the EZ Scan Plus system for home or clinical use as an aid in monitoring diabetes control.",
    "fda_folder": "Clinical Chemistry"
}